517-PXN

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name517-PXN
Drug Alias NameMDM2 inhibitor (Priaxon)517-PXN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 degraders
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsRadiation sickness +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPriaxon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPriaxon Inc
Active IndicationsN/A
Inactive IndicationsRadiation sickness +[2] 

Other Information

ATC CodeN/A
Related LinksN/A